Skip to main content

NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

gemcitabine-oxaliplatin regimen

View Patient Information

A regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer, and testicular cancer. This regimen is currently being studied in a variety of other cancers.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	GEM-OX regimen GEMOX regimen

gemcitabine-oxaliplatin regimen

Search NCI's Drug Dictionary